Canada markets closed

Krystal Biotech, Inc. (KRYS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
156.88+1.20 (+0.77%)
At close: 04:00PM EDT
159.97 +3.09 (+1.97%)
After hours: 04:20PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
50,699
50,699
0
0
0
Cost of Revenue
3,094
3,094
0
0
-
Gross Profit
47,605
47,605
0
0
-
Operating Expenses
Research Development
46,431
46,431
42,461
27,884
17,936
Selling General and Administrative
98,401
98,401
77,735
40,391
15,063
Total Operating Expenses
144,832
144,832
120,196
68,275
32,999
Operating Income or Loss
-97,227
-97,227
-120,196
-68,275
-32,999
Interest Expense
0
0
0
1,492
0
Total Other Income/Expenses Net
87,500
87,500
-25,000
-
-
Income Before Tax
12,897
12,897
-139,975
-69,570
-32,167
Income Tax Expense
1,965
1,965
0
0
-
Income from Continuing Operations
10,932
10,932
-139,975
-69,570
-32,167
Net Income
10,932
10,932
-139,975
-69,570
-32,167
Net Income available to common shareholders
10,932
10,932
-139,975
-69,570
-32,167
Basic EPS
-1.17
-
-5.49
-3.13
-1.71
Diluted EPS
-1.17
-
-5.49
-3.13
-1.71
Basic Average Shares
26,530
-
25,492
22,197
18,787
Diluted Average Shares
26,959
-
25,492
22,197
18,787